Join Today

PMC members shape and advance the future of personalized medicine.
» Sign Up Today


A Path to Personalized Heart Attack Prevention?

Although the drug was not submitted to FDA as a targeted therapy, some members of an expert group at the agency thought the cholesterol-lowering drug alirocumab, which the group recommended for approval to treat high cholesterol, should be approved only for a narrow group of people who have a genetic mutation that makes them unable to control their cholesterol with statins alone.
» The New York Times

VA Using Database to Personalize Suicide Prevention Efforts
With suicide rates among veterans rising sharply in recent years, the Department of Veterans Affairs (VA) has begun working with the National Institutes of Health (NIH) to identify subsets of high-risk patients.
» The New York Times

London-Based GeneU Aims to Personalize Skin Care
GeneU, a London-based retail store operated by an Imperial College professor and former keyboard player Nick Rhodes, has begun to apply personalized medicine concepts to the world of skin care.
» The New York Times

Member News

Agendia Co-Founder Wins European Inventor Award

Agendia Co-Founder and Research Officer Laura van't Veer, Ph.D., has won the prestigious European Inventor Award in the Small and Medium Sized Enterprises category. Van't Veer was recognized for her role as the co-inventor of Agendia's MammaPrint®, a genetic diagnostic test used to estimate the recurrence risk for breast cancer patients.
» Agendia press release (PDF)

Now Available: Video of Alliance for Aging Research Hill Briefing
The Alliance for Aging Research, in partnership with PMC and AACR, introduced a Silver Book® volume and policy fact sheet on the value in oncology of innovations like immuno-oncology and personalized medicine.
» Watch the video

Health Policy Expert Amy Jensen Cunniffe Joins WECY
Washington Council Ernst & Young (WCEY) recently announced that former White House official and health policy expert Amy Jensen Cunniffe has joined its legislative group as a principal.
» Ernst & Young press release